Thursday, February 25, 2010

HIV Drug Given to Protect a Fetus Should Be Avoided for One Year After Childbirth

http://main.uab.edu/Sites/MediaRelations/articles/74011/

February 25, 2010

BIRMINGHAM, Ala. - Women given the human immunodeficiency virus (HIV) prevention drug nevirapine to protect their fetus should not use an HIV-drug regimen that contains nevirapine for at least one year after childbirth, say researchers at the University of Alabama at Birmingham (UAB).

A new UAB study found that while nevirapine works well to prevent mother-to-child HIV transmission, a single dose of nevirapine in infected pregnant women can trigger resistance to some forms of the AIDS-drug cocktail known as combination antiretroviral treatment (ART). This nevirapine-induced resistance fades after about 12 months and no longer hinders ART, says UAB Professor of Obstetrics and Gynecology Jeffrey S.A. Stringer, M.D., the study's lead author.

----- (skipping)

.

No comments:

Post a Comment